| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | 10% Owner
2 companies
Robert C Koski is 10% Owner at HLIO and has filed Form 4s across 2 companies. Robert C Koski's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.2M at current prices.
Historically, Robert C Koski's trades have earned a strong insider score of 71/100 across 10 rated trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +22.0%.
The biggest single holding is HLIO (~$2.2M) as 10% Owner. The HLIO filings lean toward selling, a net 41,625 shares.
Robert C Koski has 26 Form 4 filings on record from May 2018 to December 2025, across 2 companies: Director at Oragenics (OGEN), 2019–2025; 10% Owner at Helios Technologies (HLIO), 2018–2019.
The 40 reported transactions were 26 open-market sales, 8 option or other derivative awards, 2 open-market purchases and 2 gifts, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $469K and 16 sales worth about $2.3M.
The only open-market purchase was 1,000,000 shares of OGEN at an average $0.47 on December 31, 2021, about $469K. Twelve months later OGEN was down 76%.
The largest open-market sale was 9,825 shares of HLIO at an average $50.37 on May 30, 2018, about $495K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2022 | OGEN Oragenics Inc | Director | Sell | 79,005 | $0.11 | $8,353.35 | -6.7% | -53.7% | -10.8% | |
| Dec 15, 2022 | OGEN Oragenics Inc | Director | Sell | 165,497 | $0.18 | $29,074.37 | -12.6% | -66.1% | -48.4% | |
| Dec 14, 2022 | OGEN Oragenics Inc | Director | Sell | 4,503 | $0.18 | $788.03 | -0.3% | -65.0% | -46.8% | |
| Dec 9, 2022 | OGEN Oragenics Inc | Director | Sell | 48,795 | $0.20 | $9,612.62 | -3.6% | -66.7% | -56.4% | |
| Dec 8, 2022 | OGEN Oragenics Inc | Director | Sell | 13,036 | $0.20 | $2,607.20 | -0.9% | -66.6% | -58.0% | |
| Nov 30, 2022 | OGEN Oragenics Inc | Director | Sell | 400,000 | $0.19 | $76,680.00 | -22.5% | -61.0% | -69.7% | |
| Dec 31, 2021 | OGEN Oragenics Inc | Director | Buy | 1,000,000 | $0.47 | $469,138.22 | +128.8% | -22.8% | -76.4% | |
| Dec 22, 2020 | OGEN Oragenics Inc | - | Sell | 310,000 | $0.43 | $132,432.00 | -28.5% | - | - | |
| Dec 30, 2019 | OGEN Oragenics Inc | Director | Sell | 200,000 | $0.52 | $104,280.00 | -15.5% | - | - | |
| Jun 27, 2019 | HLIO Helios Technologies, Inc. | 10% Owner | Sell | 2,500 | $44.32 | $110,800.00 | -7.1% | - | - |